Integrated analysis of REV-ERBα ChIP-seq and RNA-seq data revealed that among the 3,649 activated genes in the cancer cells, very small fraction is also activated in the normal cells (23 out of 1,390) (SI Appendix, Fig. S3B). This evidence concerns the gene NR1D1 and cancer.